Jamison J Grailer

Dr. Jamison J Grailer

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2016 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MKMiriam Kalbitz
Miriam Kalbitz
FFFatemeh Fattahi
Fatemeh Fattahi
THTodd J. Herron
Todd J. Herron
JGJamison J Grailer
Jamison J Grailer
LJLawrence Jajou
Lawrence Jajou
Peter A WardPeter A Ward
Peter A Ward
There is accumulating evidence during sepsis that cardiomyocyte (CM) homeostasis is compromised, resulting in cardiac dysfunction. An important role for complement in these outcomes is now demonstrated. Addition of C5a to electrically paced CMs caused prolonged elevations of intracellular Ca2+ concentrations during diastole, together with the appearance of spontaneous Ca2+ transients. In polymicrobial sepsis in mice, we found that three key homeostasis-regulating proteins in CMs were reduced: Na+/K+-ATPase, which is vital for effective action potentials in CMs, and two intracellular Ca2+ concentration regulatory proteins, that is, sarcoplasmic/endoplasmic reticulum calcium ATPase 2 and the Na+/Ca2+ exchanger. Sepsis caused reduced mRNA levels and reductions in protein concentrations in CMs for all three proteins. The absence of either C5a receptor mitigated sepsis-induced reductions in the three regulatory proteins. Absence of either C5a receptor (C5aR1 or C5aR2) diminished development of defective systolic and diastolic echocardiographic/Doppler parameters developing in the heart (cardiac output, left ventricular stroke volume, isovolumic relaxation, E′ septal annulus, E/E′ septal annulus, left ventricular diastolic volume). We also found in CMs from septic mice the presence of defective current densities for Ik1, l-type calcium channel, and Na+/Ca2+ exchanger. These defects were accentuated in the copresence of C5a. These data suggest complement-related mechanisms responsible for development of cardiac dysfunction during sepsis.

1 July 2020 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
FFFatemeh Fattahi
Fatemeh Fattahi
JGJamison J Grailer
Jamison J Grailer
MPMichella Parlett
Michella Parlett
HLHope Lu
Hope Lu
EMElizabeth A Malan
Elizabeth A Malan
Peter A WardPeter A Ward
Peter A Ward
Over the first days of polymicrobial sepsis, there is robust activation of the innate immune system, causing the appearance of proinflammatory cytokines and chemokines, along with the appearance of extracellular histones, which are highly proinflammatory and prothrombotic. In the current study, we studied different innate immune responses in mice with knockout (KO) of complement protein 6 (C6). Polymorphonuclear neutrophils (PMNs) from these KO mice had defective innate immune responses, including defective expression of surface adhesion molecules, generation of superoxide anion, and appearance of reactive oxygen species and histone release after activation of PMNs, along with defective phagocytosis. In addition, in C6−/− mice, the NLRP3 inflammasome was defective both in PMNs and in macrophages. When these KO mice were subjected to polymicrobial sepsis, their survival was improved, associated with reduced levels in the plasma of proinflammatory cytokines and chemokines and lower levels of histones in plasma. In addition, sepsis-induced cardiac dysfunction was attenuated in these KO mice. In a model of acute lung injury induced by LPS, C6−/− mice showed reduced PMN buildup and less lung epithelial/endothelial cell dysfunction (edema and hemorrhage). These data indicate that C6−/− mice have reduced innate immune responses that result in less organ injury and improved survival after polymicrobial sepsis. Key Points C6−/− mice develop less severe polymicrobial sepsis with lower mortality than Wt. C6−/− mice phagocytes have defective innate immune responses and NLRP3 activation. Septic cardiomyopathy and acute lung injury is less severe in C6−/− versus Wt mice.

16 November 2016 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
ALAndreas Lundqvist
Andreas Lundqvist
VHVincent van Hoef
Vincent van Hoef
XZXiaonan Zhang
Xiaonan Zhang
EWErik Wennerberg
Erik Wennerberg
JLJulie Lorent
Julie Lorent
AMAurélien Marabelle
Aurélien Marabelle

Verified
Journal Article
Open access
PDF file
RLRandall Loaiza
Randall Loaiza
FFFatemeh Fattahi
Fatemeh Fattahi
MKMiriam Kalbitz
Miriam Kalbitz
JGJamison J Grailer
Jamison J Grailer
MRMark W. Russell
Mark W. Russell
Peter A WardPeter A Ward
Peter A Ward
In polymicrobial sepsis, the extracellular histones, mainly released from activated neutrophils, significantly contribute to cardiac dysfunction (septic cardiomyopathy), as demonstrated in our previous studies using Echo-Doppler measurements. This study aims to elucidate the roles of extracellular histones and their interactions with Toll-like receptors (TLRs) in cardiac dysfunction. Through ex vivo assessments of ECG, left ventricle (LV) function parameters, and in vivo Echo-Doppler studies in mice perfused with extracellular histones, we aim to provide comprehensive insights into the mechanisms underlying sepsis-induced cardiac dysfunction. Langendorff-perfused hearts from both wild-type and TLR2, TLR3, or TLR4 knockout (KO) mice were examined. Paced mouse hearts were perfused with histones to assess contractility and relaxation. Echo-Doppler studies evaluated cardiac dysfunction after intravenous histone injection. Histone perfusion caused defects in contractility and relaxation, with TLR2 and TLR3 KO mice being partially protected. Specifically, TLR2 KO mice exhibited the greatest reduction in Echo-Doppler abnormalities, while TLR4 KO exacerbated cardiac dysfunction. Among individual histones, H1 induced the most pronounced abnormalities in cardiac function, apoptosis of cardiomyocytes, and LDH release. Our data highlight significant interactions between histones and TLRs, providing insights into histones especially H1 as potential therapeutic targets for septic cardiomyopathy. Further studies are needed to explore specific histone–TLR interactions and their mechanisms.

20 February 2023 in Journal of Immunotherapy
Verified
Journal Article
Open access
JGJamison J Grailer
Jamison J Grailer
ZCZhijie Jey Cheng
Zhijie Jey Cheng
JHJim Hartnett
Jim Hartnett
MSMichael Slater
Michael Slater
FFFrank Fan
Frank Fan
MCMei Cong
Mei Cong
T-cell immunotherapies are promising strategies to generate T-cell responses towards tumor-derived or pathogen-derived antigens. Adoptive transfer of T cells genetically modified to express antigen receptor transgenes has shown promise for the treatment of cancer. However, the development of T-cell redirecting therapies relies on the use of primary immune cells and is hampered by the lack of easy-to-use model systems and sensitive readouts to facilitate candidate screening and development. Particularly, testing T-cell receptor (TCR)-specific responses in primary T cells and immortalized T cells is confounded by the presence of endogenous TCR expression which results in mixed alpha/beta TCR pairings and compresses assay readouts. Herein, we describe the development of a novel cell-based TCR knockout (TCR-KO) reporter assay platform for the development and characterization of T-cell redirecting therapies. CRISPR/Cas9 was used to knockout the endogenous TCR chains in Jurkat cells stably expressing a human interleukin-2 promoter-driven luciferase reporter gene to measure TCR signaling. Reintroduction of a transgenic TCR into the TCR-KO reporter cells results in robust antigen-specific reporter activation compared with parental reporter cells. The further development of CD4/CD8 double-positive and double-negative versions enabled low-avidity and high-avidity TCR screening with or without major histocompatibility complex bias. Furthermore, stable TCR-expressing reporter cells generated from TCR-KO reporter cells exhibit sufficient sensitivity to probe in vitro T-cell immunogenicity of protein and nucleic acid-based vaccines. Therefore, our data demonstrated that TCR-KO reporter cells can be a useful tool for the discovery, characterization, and deployment of T-cell immunotherapy.

25 November 2025 in Journal of Virology
Verified
Journal Article
Open access
JMJonathan K. Mitchell
Jonathan K. Mitchell
VMVincent Mastrodomenico
Vincent Mastrodomenico
JHJim Hartnett
Jim Hartnett
WHWilliam J. Heelan
William J. Heelan
DGDenise Garvin
Denise Garvin
JGJamison J Grailer
Jamison J Grailer
Accurate quantification of virus neutralization is essential for evaluating the efficacy of vaccines and antibody-based therapies. However, conventional neutralization assays require strict biocontainment or utilize surrogates of infection that increase biosafety but reduce biological relevance. These limitations create critical bottlenecks for the timely development of antiviral immunotherapeutics. Here, we describe a neutralization platform using non-replicating, HiBiT-tagged pseudovirus-like particles (HiBiT-PsVLPs) for safe yet biologically relevant assessment of neutralization. These HiBiT-PsVLPs package the HiBiT protein tag internally and incorporate glycoproteins from pathogenic viruses to recapitulate entry at reduced biosafety levels. Unlike traditional pseudoviruses, HiBiT-PsVLPs lack reporter genes and employ the NanoBiT split luciferase system for rapid, complementation-based luminescent readout of entry and neutralization. Using the SARS-CoV-2 Spike protein as proof-of-concept, we demonstrate efficient pseudotyping, entry, and neutralization of HiBiT-PsVLPs. HiBiT-PsVLP neutralization is specific, reproducible, and reflective of antibody potency and stability. Assay results align closely with an established surrogate virus neutralization test (sVNT), with HiBiT-PsVLPs capturing more diverse mechanisms-of-action (MoAs). Moving beyond SARS-CoV-2, we adapt the HiBiT-PsVLP platform for other clinically relevant viruses, including HIV-1 and emerging pathogens, such as Ebola, Marburg, Lassa, and Nipah viruses. By pairing HiBiT-PsVLPs with Fc gamma receptor (FcγR)-expressing cells, we also demonstrate the capability of this system to detect antibody-dependent enhancement (ADE) of virus entry as an important safety consideration for immunotherapies. Combined, these data establish the utility of the HiBiT-PsVLP platform for safely and rapidly measuring critical antibody activities across diverse viruses and drug development stages. IMPORTANCE: Standard neutralization assays are often slow, labor-intensive, and restricted to high-containment facilities, thus complicating and delaying the development of vaccines and antibody-based treatments. Here, we present a novel neutralization assay system using HiBiT-tagged pseudovirus-like particles (HiBiT-PsVLPs). These particles incorporate entry proteins from diverse pathogenic viruses but are non-replicating and lack viral nucleic acids, thus mitigating the biosafety risks of conventional assays. The particles encapsulate the HiBiT peptide, enabling rapid, luminescent quantitation of entry and neutralization. We demonstrate that this platform accurately measures neutralizing activity of monoclonal antibodies across development stages and sensitively detects antibody-dependent enhancement, a critical safety consideration. Altogether, HiBiT-PsVLPs offer a safe, rapid, and scalable platform to accelerate the development of vaccines and antibody therapeutics targeting a broad range of viruses.